drugset / Trial / NCT01910532

The Evaluation of Clevidipine in Patients Requiring ICP Monitoring and IV Antihypertensive Therapy

NCT01910532

Phase 4 Withdrawn Mario Ammirati
NaSingle-groupOpen-labelTreatment

Summary

This is a single-arm, open label safety and dose titration study evaluating the use of Clevidipine to rapidly control elevated blood pressure in patients who have an Intracranial Pressure Monitoring device.

Timeline

Start
2010-04
Primary completion
2012-11
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Clevidipine Small molecule

Indications